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Growing pressure on hospital systems to reduce readmissions, including efforts by the Centers for
Medicare & Medicaid Services (CMS) to penalize hospitals with high readmission rates, coupled with
limited inpatient bed and staff availability have placed even more focus within health systems on
appropriately managing patients with chronic conditions in the most cost-effective setting. Traditional
readmission reduction programs have centered on efforts within the acute care setting, however
continued improvement requires leveraging transitional care programs to ensure health care continuity,
prevent poor outcomes and promote safe and timely transfer of patients from the inpatient to
outpatient setting. This dissertation examines the potential impact of two such transitional care
programs and their effects on hospital readmissions: establishing patients in a disease management
clinic and the development of a post-discharge in-home visit.
Methods
My study begins with the review of published literature on the various programs that have been
deployed and shown to be effective chronic care management strategies and readmission reduction
prevention programs. My next manuscript describes the development of a care transition program
utilizing a chronic care disease management outpatient clinic, which was established as a bridge to
outpatient management for low and underserved patient populations. Finally, my third manuscript
examines the development of a care transition program utilizing a post-discharge in home visit with
additional telephone support. Both of these programs were implemented at a medium sized (<250 bed)
rural hospital in Southeast Texas. These studies attempt to add to the current literature base regarding
outpatient chronic care management strategies.
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Results
These studies demonstrate that implementing transitional care programs can be effective in reducing
hospital readmissions in targeted populations. Establishing patients in an outpatient disease
management clinic showed a reduction in overall inpatient utilization. The second study showed that
enrolling traditional Medicare patients in a home-based transitional care visit program was associated
with a reduction in hospital all-cause 30 day readmissions.
Conclusion
This program provides further evidence that a care transition program can bridge the gap between
discharge and the next level of care through an outpatient disease management program. Expansion of
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Thesis Overview
Manuscript One: Literature Review
The literature review identified four main readmission reduction strategies for consideration in a
hospital’s chronic care management program. Project RED’s comprehensive toolkit for improvement of
the discharge process focuses on ensuring that the transitional care elements are in place prior to
discharge. Telephone based reinforcement programs focus on monitoring, education, and self-care
management (or combinations thereof) using telephone support after discharge in a structured format
(e.g., series of scheduled calls with a specific goal, structured questioning, or use of decision support
software). Home-visit based care programs included education or training focused on self-care, diet,
medications, and early recognition of symptoms that may indicate a need to seek further intervention.
Outpatient clinic based follow-up care focuses on services provided in one of several different types of
outpatient clinics (disease specific or primary care).
Overall, intervention categories that included higher-intensity interventions (e.g., home-visiting
programs, outpatient clinic-based follow up care) showed trends in reducing all-cause readmission or
mortality. By contrast, categories with lower-intensity interventions (e.g., primarily educational
interventions, stand-alone telephone based reinforcement) did not affect hospital readmissions in a
meaningful way. These findings suggest that intensity of resource use should be a key decision point
when determining intervention selection based on each local health care market.
Manuscript Two: Chronic Care Management: A Disease Management Clinic -
based Transitional Care Model for Readmission Reduction
In this manuscript, the establishment of a disease management clinic is described as one hospital’s
effort in establishing an outpatient home for low income and underserved populations. Chronic
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diseases, especially congestive heart failure (CHF) continue to be a challenge to hospitals as their care
plans are now extending beyond that of the inpatient realm. To that end, a clinic was established by the
hospital as a way to find an appropriate clinical setting for patients who experienced signs and
symptoms of CHF exacerbation, and who could ultimately be treated effectively in an outpatient setting.
This clinic was founded in 2014 with the goal of providing a transitional home for CHF patients who had
no established primary care physician or cardiologist. The function of the clinic was to potentially divert
chronic CHF patients from the hospital’s Emergency Department and towards a more cost-effective
clinic setting and by doing so, reduce readmissions at the hospital.
The disease management clinic is primarily staffed with an RN, nurse practitioner, and a dietitian to
address the clinical needs of the patients presenting to the clinic. The clinic also includes the services of
disease management navigators, licensed clinical social workers, financial counselors, exercise
physiologists, CNAs, and respiratory therapists. The services of the mid-level providers support the work
of the specialists to empower high-risk individuals to take charge of their own health and to access the
appropriate level of care. The clinic visit includes an extensive questionnaire, screening, assessment by
a nurse practitioner, and medication reconciliation. Education is provided individually to patients,
according to their physical and/or emotional status.
This results of this study demonstrate that an outpatient disease management clinic which focuses on
education, counseling, and medication titration of heart failure patients can be successful in reducing
hospital readmissions. When comparing overall CHF patient discharges compared to enrolled disease
management clinic patients, patients who are enrolled in the clinic had fewer 30-day (all cause)
readmissions. Over the previous 4 years, only 7.9% of HF clinic patients experienced a readmission,
compared to 15.8% of the general HF population not enrolled in the clinic.
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Year over year improvements in the HF clinic readmission rates may indicate the cumulative success of
the educational interventions, overall clinic effectiveness and ability of the clinic staff to effect
meaningful difference in the behaviors of the enrolled population.
This study serves as further evidence of a successful demonstration for leveraging a care transition
program to bridge the gap between discharge and next level of care through an outpatient disease
management program.
Manuscript Three: Chronic Care Management: A Home-based Transitional
Care Model for Readmission Reduction
This manuscript describes the development of a care transition program utilizing a post-discharge in
home visit with additional telephone support implemented at a medium sized (<250 bed) rural hospital
in Southeast Texas. The targeted patient population for program participants included traditional
Medicare enrollees (aged 65 and older) who were admitted to the hospital between July and December,
2017 with a primary diagnosis of heart failure.
The purpose of the in-home visit is to assess clinical stability of the patient in home, and provide post-
acute care for the purpose of disease management follow-up by promoting patient engagement, self-
management and support post hospital discharge. After the initial in-home visit, the care management
call center contacts the patient weekly for the next three weeks. Patients are also encouraged to utilize
the 24/7 telephone support for any questions or medical issues that arise.
These touchpoints with the patient promoted patient engagement, self-management and support to
encourage the patient to continue communication with their care team after home health discharge
(transition to the community); focused on keeping communication open between patient and primary
care physician to ensure appropriate patient support; ensured that the patient has access to any needed
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community and caregiving services; conducted ongoing and continual medication reconciliation; and
continued a focus on the importance of medication adherence.
At the time of writing of this article, the care transition in-home program has been operational for six
months. During that period of time 67 patients were enrolled in the program.
By design, the study focused on early intervention and frequent touchpoints. The initial in-hospital visit
was conducted as close to discharge as possible to increase the likelihood of patient adherence to the
program and likelihood that the education delivered would be enduring. Likewise, the majority of the
initial call center initiated calls occurred within 24 hours of discharge and the transitional care in home
visit within the first 7 days. All 67 patients initially enrolled in the program successfully made it to their
next level of care visit (PCP, Cardiology, etc.). This element was a major focus of the program; that is,
keeping patients healthy until their next level of care. Most importantly, none of the 67 patients
enrolled in the program were readmitted to the hospital within 30 days of discharge.
Based on the findings from this study, the care transition in-home visit was shown to be an effective
readmission reduction strategy. Initial success in this program demonstrates the potential benefit to
scaling this effort to reach a larger percentage of the CHF discharged population.
Implications for Practice and Policy
Practice: This study has several implications for clinical practice in hospitals looking to reduce
readmissions among chronic disease patients. First, as emergency departments continue to be over
utilized for less than emergent conditions, reducing the patient burden is increasingly important. Finding
an appropriate, cost-effective treatment venue for patients in the outpatient arena is key to reducing
the stress on emergency departments.
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Second, by reducing readmissions to the hospital, patients are able to maintain a healthier state free
from symptom exacerbation and further complications. Referring inpatients to a transitional care
program should be considered for practitioners (and hospitals) as a front line treatment regimen to
bridge care between the inpatient discharge and the next level of care (PCP or cardiology office visit).
Policy: Hospitals and health systems should consider their unique role in community risk assessment
when investigating appropriate transitional care programs to implement. The literature review
demonstrated that although low cost interventions (e.g., telephone based intervention) may be the
easiest to implement, without additional home-based support these were not likely to have the desired
overall effect. Additionally an outpatient clinic based approach may not be optimal in an area where
access to private transportation or public transportation is limited. In these areas, a home-visit based
program may be ideally situated for reaching these patients. However, in areas in which there are
limited outpatient settings, and limited home-care based groups an inpatient-focused strategy (e.g.,
Project Re-Engineered Discharge) should be considered as a viable option.
Hospitals which are subject to the CMS penalties for excess readmissions should consider a transitional
care approach to compliment an inpatient strategy. These transitional care programs have been
demonstrated as effective readmission reduction strategies, and further efforts around their
establishment as an adjuvant inpatient strategy should be considered.
Furthermore, preventing patients from being readmitted to the hospital is key in reducing not only
inpatient utilization, but high costs to the healthcare system. Treating a patient in an outpatient setting
has a much lower cost than delaying treatment until inpatient utilization is necessary. Further policy




As inpatient demand is often outpacing bed and/or staff availability in Southeast Texas, finding the
appropriate setting to care for patients with chronic conditions becomes more and more important.
CMS pressure to reduce readmissions by penalizing hospitals with higher average readmissions further
emphasizes the importance of platforms like these care transition programs.
These studies provide the health and supportive resources needed to empower patients and their
caregivers to take charge of their health and access and utilize services appropriately. Based upon
evidence from similar interventions, these efforts hope to create a significant reduction in
hospitalizations, readmissions, and inappropriate emergency department utilization among those
served. Care transition programs should be considered as a strong candidate for reducing hospital
readmissions in targeted populations.
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Chronic care management programs focusing on transitional care are a prevalent component of
population health strategies aimed at reducing inpatient overutilization. As health care institutions have
focused more attention on transitions of care and outpatient management strategies, reductions in
hospital readmissions and overall lower cost of care have been demonstrated. This paper will review
the various programs that have been deployed and shown to be effective chronic care management
strategies, and which serves as a guide for health care organizations seeking to implement similar
transitional care based readmission reduction efforts.
Background
The Affordable Care Act of 2010 established the Hospital Value Based Purchasing (VBP) Program, which
applies to payments that began in Fiscal Year (FY) 2013. The VBP program affects payment for inpatient
stays based on relative performance across the county. In the FY 2012 inpatient prospective payment
system final rule, CMS finalized the policies that would establish a program to penalize hospitals with
high readmission rates. This program puts Medicare dollars at risk based on the relative performance of
the hospital in several key disease categories. This program also put pressure on healthcare
organizations to manage patients outside of the inpatient setting. The readmission reduction program
set up the following criteria1:
• Defined readmission as an admission to a hospital within 30 days of a discharge from the same or
another hospital; (specific to ‘unplanned readmissions’)
• Adopted readmission measures for the applicable conditions of acute myocardial infarction (AMI),
heart failure (HF), and pneumonia (PN);
• Established a methodology to calculate the excess readmission ratio for each applicable condition,
which is used, in part, to calculate the readmission payment adjustment. A hospital’s excess
3
readmission ratio is a measure of a hospital’s readmission performance compared to the national
average for the hospital’s set of patients with that applicable condition.
• Established a policy of using the risk adjustment methodology endorsed by the National Quality
Forum (NQF) for the readmissions measures to calculate the excess readmission ratios, which includes
adjustment for factors that are clinically relevant including certain patient demographic
characteristics, comorbidities, and patient frailty.
In addition, CMS finalized the expansion of the applicable conditions beginning with the FY 2015
program to include: (1) patients admitted for an acute exacerbation of chronic obstructive pulmonary
disease (COPD); and (2) patients admitted for elective total hip arthroplasty (THA) and total knee
arthroplasty (TKA). Trends in the readmission reduction and value based purchasing programs
demonstrate the expansion of government programs and target reducing healthcare costs by focusing
on preventable readmissions. Accordingly, health care organizations are under increasing pressure to
establish programs to manage chronic care in efficient ways. These governmental programs have had far
reaching effects. Medicare under the Hospital Readmissions Reduction Program (HRRP) will reduce
reimbursement for 2,573 hospitals for fiscal year (FY) 2018, according to CMS data2. The latest penalties
are based on readmissions between July 2013 and June 2016. The penalties will apply to Medicare
payments that CMS makes to the affected hospitals between Oct. 1, 2017 and Sept. 30, 2018. Under the
HRRP, CMS withholds up to 3 percent of regular reimbursements for hospitals if they have a higher-
than-expected number of readmissions within 30 days of discharge for the six conditions included in the
program.
According to a Kaiser Health News analysis of the data, about 80 percent of the 3,241 hospitals CMS
evaluated in 2017 will face penalties. The number of penalized hospitals in FY 2018 (2,573) marks a
slight decline from FY 2017, when Medicare reduced reimbursements for 2,597 hospitals3.
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But are these government programs effective for changing outcomes? Preliminary results indicate that
they are. A study from 2016 in the New England Journal of Medicine found that readmissions for the
conditions Medicare focuses on fell from 21.5 percent in 2007 to 17.8 percent in 20154. A
separate study found that readmissions fell more quickly at hospitals that could face the readmission
penalty than at other hospitals5.
Heart failure has been a focus of the readmission reduction penalty program since its inception largely
due to the net potential of that patient population. A previous analysis of Medicare claims data from
2007 to 2009 found that 35% of readmissions within 30 days were for HF6. More recent studies have
stated that up to 25% of patients hospitalized with HF are readmitted within 30 days7 8. As a result,
tailored interventions are needed to curtail readmissions in this population.
Programs that are targeted to preventing readmission are frequently referred to as ‘transitional care
interventions’, describing how they bridge the inpatient care and outpatient environment (including a
patient’s return home). These transitional care interventions have been defined as “a broad range of
time-limited services designed to ensure health care continuity, avoid preventable poor outcomes
among at-risk populations, and promote the safe and timely transfer of patients from one level of care
to another or from one type of setting to another”9.
So how have these hospitals been able to accomplish these reductions? In the following sections we will
explore a number of these studies and review the various transitional care strategies that have been
deployed aimed at reducing hospital readmissions, and subsequent readmission penalties.
Study Methodology
Potential studies were identified through literature review using electronic search, primarily focusing on
those published since the Affordable Care Act was established in 2010. Although numerous studies
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existed prior to 2010, the literature review focused on those that may have been impacted by the VBP
legislation. The search focused primarily on HF, based on the disease prevalence and chronic nature of
this disease in the 65+ year old population and the prevalence of literature associated with it (although
other interventions with similar disease states were not excluded). Studies were grouped according to
overall program focus and organized by intervention focus and setting. Rationale for this grouping was
done in an effort to allow for review and consideration of the programs available to healthcare
organizations considering readmission reduction strategies suitable for their individual markets.
Based on this literature review, the studies have been organized according to the following
interventions shown in Table 1. Each Program will be described in detail in the subsequent sections.
Program Focus
Project RED (comprehensive) Toolkit for improvement of the discharge process
(Acute Care focus). Program focus is to ensure that
the transitional care elements are in place prior to
discharge.
Telephone based reinforcement Monitoring, education, and self-care management
(or combinations thereof) using telephone support
after discharge in a structured format (e.g., series of
scheduled calls with a specific goal, structured
questioning, or use of decision support software).
Home-visit based follow up care Home-visit based care programs included education
or training focused on self-care, diet, medications,
and early recognition of symptoms that may indicate
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a need to seek further intervention.
Outpatient clinic based follow-up care Services provided in one of several different types of
outpatient clinics—multidisciplinary-HF, nurse-led
HF, or primary care clinic. The clinic-based
intervention can be managed by a nurse or other
provider depending on the site of service.
Table 1: Reviewed Interventions for Transitional Care
• Project Re-Engineered Discharge
Project Re-Engineered Discharge was designed by a research group at Boston University Medical Center
that develops and tests strategies to improve the hospital discharge process in a way that promotes
patient safety and reduces re-hospitalization rates. The RED (re-engineered discharge) intervention was
founded on eleven discrete, mutually reinforcing components and has been widely utilized to reduce re-
hospitalizations with an additional benefit of increased patient satisfaction outcomes10. This program
differentiates itself from other studies reviewed here in that it focuses largely on actions prior to
discharge. The program focus is ensuring that the patient is educated prior to discharge and includes
plans for the coordination of the next level (outpatient) of care.
Project RED begins with patient education throughout the hospital course. During this education staff
work with the patient to schedule follow-up appointments with the next level of care (e.g., Cardiology
for heart failure patients) and any additional tests as indicated during their length of stay. Hospital staff
are also tasked with ensuring any outstanding tests that were administered during the inpatient stay
and which are reported after discharge are followed up on. Staff organize post-discharge services,
including home health or other outpatient services. The patient medication plan is reviewed with the
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care team and all medications are reconciled prior to discharge. Hospital staff then review a
communication plan with the patient to ensure that there is an established pathway and steps for if/
when a problem arises post discharge. The medical record, primarily the discharge summary, is then
transmitted to the primary care physician. Immediately prior to discharge the patient is assessed for
his/her understanding of the discharge plan, and any additional educational interventions required as a
result are conducted. A copy of the written discharge plan is then provided to the patient, and finally a
telephone call reinforcing the plan is conducted post-discharge.
Project RED relies on inpatient staff or hospital organized staff to accomplish the eleven elements of the
program, as described above. Often, nursing personnel and case management staff are most readily in a
position to accomplish these components, but this work must also be balanced with their normal
workload and tasks.
• Home-visit based follow up care
Home-visit based follow up care can be accomplished by leveraging a home health company or directly
through use of hospital staff trained in home health management. Typical home-visit based care
programs include education or training (or both) focused on self-care, diet, medications, and early
recognition of symptoms. Many of these programs delivered educational components before discharge
as well as during home visits. Initial inpatient screening by case management can identify patients that
may be ideal candidates for a home-based care transition visit. After the referral to home health, a
home health care transition coordinator (who often works for the home health provider) sees the
patient while still in the hospital to establish a relationship prior to setting foot in the patient’s home.
Most home visits began within 7 days of discharge; three reviewed studies included visits within 24 to
48 hours of discharge11 12 13, and three additional studies specified that visits occur within 14 days of
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discharge14 15 16. All reviewed studies included education or training and focused on self-care, diet,
medications, and early recognition of symptoms.
Typically for high risk patients, the clinician will meet with the patient in-home within 24 hours of
discharge17 and complete a patient assessment. Patient assessments are meant to be a broad ranging
evaluation of the patient’s physical and socioeconomic limitations, including: 1) an assessment of
barriers to care (e.g., environment, social support system, transportation, food, drug cost/access),
connecting the patient with other disciplines (e.g., social work) to further assess, and connecting with
community resources as needed; 2) assessment of the patient’s need for other disciplines (e.g., OT, PT,
MSW services); and 3) assessment of the patient’s (and family’s) health literacy needs in order to
develop a home health plan of care, including goals and coaching/teaching needs18.
An additional core component of a home health care transition program is patient education and follow-
up coordination of health care services19. Patient education focuses on ensuring the patient knows how
to contact the referring home health agency during and after hours, reviewing advanced directives with
the patient, discussion of the plan of care and frequency of visits, and explaining how to recognize those
clinical signs and symptoms with which to be concerned. Follow-up coordination of health services
includes conducting medication reconciliation and communication with the primary care physician and
pharmacist (as needed) and verifying that required follow-up appointments with specialty providers
were made.
Subsequent encounters made by the home-visit care transition team should promote patient
engagement and self-management. The home-visit team should also encourage the patient to continue
communicating with appropriate physicians and other identified care providers after home health
discharge (transition to the community) to ensure the care plan is followed, conduct ongoing medication
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reconciliation and assure medication adherence, and coordinate with other appropriate support
services.
For moderate-risk patients, the clinician frequently meets with the patient within 48 hours of hospital
discharge20. The clinician and home health team can then plan a follow up in-person visit or other
contact (such as telephone or videoconferencing). Two trials reviewed included planned, structured
telephone calls in addition to home visits21 22. Early clinician follow-up (clinic visit or other in-person
support) was common practice in these programs in which interventions offered additional telephonic
support for questions or advice throughout the intervention.
Home-visit based follow up care can be accomplished by an RN, LVN or other clinically trained personnel
(case management or pharmacy staff have been used in some sites).
• Outpatient Clinic-Based follow up care
Outpatient clinic-based follow-up care can broadly be described as services provided in one of several
different types of outpatient clinics—multidisciplinary, nurse-led, or primary care clinic. The clinic-based
intervention can be managed by a nurse or other provider depending on the site of service. As a whole,
these clinic based settings focus on education, emphasizing self-care, recognition of symptoms, and
weight monitoring.
Six studies were reviewed that specifically focused on HF clinic interventions that involved an emphasis
on physician contact and access to a multidisciplinary care team (cardiology, nurses, dieticians,
pharmacists) in contrast to other nurse-led clinics23 24 25 26 27 28. Two additional studies described as
nurse-led focused more on patient education delivered by nurses during scheduled clinic appointments
than on multidisciplinary management29 30.
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In general, most trials included an educational component. Two trials included education on self-care
delivered before discharge and education reinforcement during telephone follow-up31 32.
One trial focused on improved access to primary care through allowing reserved appointment slots in
the scheduling block33. These services coordinated care with a patient’s primary care physician by
scheduling appointments for acute needs or alerting physicians to changes in symptoms34 35.
Pharmacotherapy is often a primary focus of these clinics, which emphasizes patient education about
medications, promotion of adherence to their medication schedule, and promotion of evidence-based
pharmacotherapy before discharge or during follow-up (or both). These clinics utilize face-to-face
contact following discharge. In most studies reviewed, this contact occurred within 7 days of discharge.
Mechanisms to contact care delivery personal (clinic personnel or pharmacists) outside of scheduled
visits or normal office hours were often a primary component of the program (e.g., patient hotline). In
most cases, home-visiting personnel either directly recommended medication adjustment or assisted
with coordination of care (e.g., with primary care provider or cardiologist) to facilitate timely medication
adjustment, based on a patient’s needs rather than advising patients to call for help themselves.
All studies reviewed involved a series of scheduled outpatient clinic visits following discharge, beginning
within 7 days after the hospital discharge or enrollment, and individualized care planning. These studies
did not describe scheduled home visits as a part of the program. The studies described the use of usual
care that included management in accordance with current clinical practice or stated that patients
received conventional follow-up in primary health care.
• Telephone Based Reinforcement
Telephone based reinforcement is similar in nature to educational based initiatives, and primarily serve
as a means to check-in on patients once the transition to their homes has occurred. These programs
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focus on patient monitoring, education, and/or self-care management (or various combinations) after
discharge in a structured format (e.g., series of scheduled calls with a specific goal, structured
questioning, or use of decision support software).
All studies reviewed involved a series of scheduled, structured telephone calls to patients following
discharge. Studies typically described one or two calls during the intervention period. In most studies,
the first telephone contact was within 7 days of discharge; in one, the first call occurred at 2 weeks after
discharge36; and two trials did not describe the timing of the first call37 38. Most calls were delivered by
nurses; two studies included calls made by a pharmacist39 40.
All studies reviewed included some element of patient education. In most, education or self-care
training began prior to discharge and was reinforced after discharge during telephone follow-up, but
some did not include an educational component before discharge41 42 43 44 45 46. Five of the six reviewed
studies included a patient-initiated call (optional) as support for questions that arose after discharge.
The specific messages/ content and qualifications of the individual initiating the telephone support in
each of these studies varied. The following interventions were also noted, but were not consistently
represented in the studies reviewed: One study involved case management intervention at the time of
discharge which included care coordination with primary care and individualized discharge planning
(e.g., obtaining needed services for patients such as physical therapy, and facilitating communication in
the hospital among the family and providers)47; other studies also included a focus on inpatient
intervention that optimized evidence-based pharmacotherapy before discharge48.
Study Results
• Project Re-Engineered Discharge
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Memorial Hospital, a 97-bed community hospital in Marysville, Ohio, uses strategies from AHRQ's Re-
Engineered Discharge toolkit to help newly discharged patients follow their treatment plans and
improve their health in order to avoid readmission to the hospital. With this practice, the hospital's
readmission rate declined to single-digit percentages. After ten months of making follow-up phone calls,
the readmission rate for congestive heart failure patients averaged 9.1 percent, compared with 15.4
percent for the previous 9-month period. During the same time frame, COPD readmissions declined
from 20.6 to 11.8 percent, while the readmission rate for pneumonia patients fell from 10 to 9.7
percent49. The study did not indicate the hospital overall volume of admissions during the intervention
timeline, so it is unclear whether decreased readmissions were markedly affected by a shift in volume
(however no author comments suggest otherwise).
Penn Medicine Chester County Hospital, a 257-bed complex in West Chester, Pennsylvania, part of the
University of Pennsylvania Health System, was one of 10 hospitals involved in AHRQ's 2011 rollout of the
Re-Engineered Discharge toolkit. The readmission rate for heart failure was reduced by 50% to 14%
overall50.
Three California hospitals are among those in the San Francisco-based Dignity Health System using
AHRQ's Re-Engineered Discharge Toolkit to reduce hospital readmissions and improve care transitions.
Bakersfield Memorial saw 30-day readmissions for Medicare patients drop over a 6-month period that
ended June 2014 to 11.3 percent from 25 percent, based on a similar period that ended in late 2013; all-
payer 30-day readmissions dropped to 6.5 percent between January and July 2014 from an average of
7.5 percent in 201351. This study did not detail non-project RED interventions at the same facilities
which may or may not have affected overall program success.
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St. Mary’s Medical Center, a 389-bed trauma center in Long Beach, introduced RED in December 2013
for heart failure patients and saw readmissions for this population drop to 7.7 percent as of July 2014
from 22.2 percent in November 2013, helping to reduce all-cause readmissions to 5.7 percent52.
San Francisco’s 300-bed St. Mary’s Medical Center also introduced RED with heart failure patients,
which helped the facility reduce the hospital’s overall readmissions rate by more than 20 percent, to 5.5
percent in June 2014 from 7.6 percent in January 201353.
• Home-visit based follow up care
One home-visiting trial showed efficacy in reducing both 30-day and all-cause readmission rates54. In the
trial by Naylor et al., an advanced practice nurse conducted the home visit within 24 hours of discharge,
and a total of eight home visits were planned. In the trial by Jaarsma et al., patients were called within 7
days following discharge to schedule a follow-up in home visit; most visits were scheduled within 10
days of discharge and no additional visits were planned. The trial by Naylor et al., which evaluated a
more intensive intervention, found a lower risk of readmission for patients receiving home visits than for
patients in the control group (RR, 0.34; 95% CI, 0.19 to 0.62)55. The trial by Jaarsma et al. found no
difference in all-cause readmission between patients receiving the home visit and patients in the control
group (RR, 0.89; 95% CI 0.43 to 1.85)56. Over 3 to 6 months, the meta-analysis study conducted by the
Effective Heath Care Program, (which included nine trials) found that patients receiving home visits had
a significantly reduced risk of all-cause readmission (RR, 0.75; 95% CI, 0.66 to 0.86)57.
At 3 months, one trial (N=282) found that patients receiving home visits had a significantly lower risk of
HF-specific readmissions than controls (RR, 0.51; 95% CI, 0.31 to 0.82)58. Another trial (N=200) reported
that patients receiving home visits had significantly fewer total HF specific readmissions than did
patients receiving usual care (RR, 0.54; p<0.001)59.
14
• Telephone Based Reinforcement
One trial (N= 134) by Feltner et al., reported all-cause readmission at 30 days; the readmission rate did
not differ between patients receiving structured telephone support (STS) from those receiving no
telephone support (RR, 0.80; 95% CI, 0.38 to 1.65)60. Over 3 to 6 months, “the meta-analysis conducted
by the EHCP looking at telephone based interventions (N=8) found no difference in the relative risk of
all-cause readmission between patients receiving STS and those receiving usual care (RR, 0.92; 95% CI,
0.77 to 1.10) 61.
• Outpatient Clinic-Based follow up care
Among the Outpatient Clinic-Based HF interventions, the Effective Heath Care Program’s analysis of
outpatient clinic-based follow up care (two trials) found that patients receiving the intervention had a
significantly lower risk of all-cause readmission than patients not receiving care at a disease
management based clinic (RR, 0.70; 95% CI, 0.55 to 0.89). Over 3 to 6 months, the same analysis found
that patients receiving a nurse-led clinic intervention and those receiving usual care had a similar risk of
all-cause readmission (RR, 0.88; 95% CI, 0.57 to 1.37)62 63.
Commentary
From the Comparative Effectiveness meta-analysis, the authors identified two categories of standalone
interventions that reduced all-cause readmissions; home-visiting programs and HF clinic-based
interventions64. There have been limited studies outside of the Comparative Effectiveness study that
were applicable to the transitional care elements discussed here. When reviewing these studies, the
categories of interventions (Project RED, telephone support, clinic based intervention and in-home
visits) in reality are rarely standalone interventions. For example, in practice, outpatient clinic based
care is often accompanied with a telephone support system, or a home-visit based program. It is of note
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that typical telephone based support programs are outbound programs, that is, the care team
proactively calls the patient to assess their health status.
The 2013 American Heart Association/American College of Cardiology (AHA/ACC) Heart Failure
guidelines addressed post discharge HF specific interventions. These guidelines focus on the importance
of optimizing HF pharmacotherapy before discharge, providing HF education before discharge (including
self-care management), and addressing barriers to care among other factors. These guidelines included
a recommended follow-up visit within 7 to 14 days of discharge or a telephone follow-up within 3 days
of discharge65. The AHA/ACC guidelines also recommend initiating multidisciplinary HF disease
management programs for patients at high risk for readmission66. However, the AHA/ACC did not
provide definitive guidance on the recommended components of transitional care interventions aimed
at preventing readmissions for patients with HF.
In concert with the AHA/ACC and based on a review of the literature discussed here, five elements seem
to be effective themes for addressing all-cause readmissions, including:
1. Education focused on self-care, which can be instituted prior to discharge and reinforced
throughout the transition of care episode.
2. Focus on pharmacotherapy and the importance of ensuring access to home medications and
adherence to their prescription regimen.
3. Early contact following discharge (which can come in the form of a home visit or outpatient
follow-up) to help ensure any home based lifestyle barriers are mitigated.
4. A process for patients to contact personnel as problems arise or symptoms worsen (e.g.,
telephone support)
5. A mechanism that allows the intervention to be individualized to the patient’s specific needs
(including early adjustment of medications based on symptoms)
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Each of the studies reviewed focused on reducing hospital readmissions as the ultimate gauge of success
for each program, however the impact on quality of life should also be considered. Resource availability
and the start-up and operating costs of the respective program types should also be a determining
factor, which, although not discussed in this review, should be evaluated in subsequent studies.
Based on the significant dollars placed at risk by the VBP hospital readmission reduction program,
hospitals aiming to reduce HF readmissions may be able to reduce readmission rates by implementing
programs that employ one or more of the five AHA/ACC elements discussed previously. Although
telephone based intervention may be the easiest to implement, without additional home-visit support,
this intervention is less likely to have the desired overall effect. Likewise, an outpatient clinic based
approach, based on the data, may not be optimal especially in rural areas or where access to
transportation is limited. In these areas, a home-visit based program coupled with a provider initiated
telephone support system may be ideally situated for reaching these patients. In areas in which there
are limited outpatient settings, and limited home-care based groups an inpatient focused strategy (e.g.,
Project Re-Engineered Discharge) coupled with a provider-initiated telephone support system may be
the best available option. Project RED was included in this review although it was not a focus of the
Comparative Effectiveness Review, but rather a related intervention that included several interventions,
and focused largely on efforts within the inpatient setting.
Overall, intervention categories that included higher-intensity interventions (i.e., home-visiting
programs, telephone based reinforcement, outpatient clinic-based follow up care) showed trends in
reducing all-cause readmission or mortality. By contrast, categories with lower-intensity interventions
(i.e., primarily educational interventions) did not affect hospital readmissions in a meaningful way.
These findings suggest that intensity of resource use should be a key decision point when determining
intervention selection, which also should be tailored to each local health care market.
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Manuscript Two: Chronic Care Management: A
Disease Management Clinic-based Transitional
Care Model for Readmission Reduction
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Abstract
Chronic care management programs focusing on transitional care have become prevalent as a
component of population health strategies aimed at reducing inpatient overutilization. Chronic
diseases, including congestive heart failure (CHF) continue to be challenges to hospitals as their care
plans are now extending beyond that of the inpatient realm. Even from the hospital perspective,
treatment of these diseases can no longer exist solely within the inpatient setting. To that end, this
paper will describe the development of a care transition program utilizing a chronic care disease
management outpatient clinic founded in 2014 at a medium sized (<250 bed) rural hospital in Southeast
Texas. Results of the program demonstrate the clinic’s effectiveness as a transitional care component
for patients with no established primary care or cardiology home in preventing inpatient readmissions.
Background
The Affordable Care Act of 2010 established the Hospital Value Based Purchasing (VBP) Program, which
affects payment for inpatient stays based on relative performance across the county. In subsequent
years CMS finalized the policies that would establish the program to penalize hospitals with high
readmission rates of patients with specific conditions including heart failure (HF) and patients admitted
for an acute exacerbation of chronic obstructive pulmonary disease (COPD)67. As a result of this penalty
program, Medicare under the Hospital Readmissions Reduction Program will reduce reimbursement for
2,573 hospitals for fiscal year (FY) 201868.
Heart failure has been a focus of the readmission reduction penalty program since its inception largely
due to the net potential of that patient population. A previous analysis of Medicare claims data from
2007 to 2009 found that 35% of readmissions within 30 days were for HF69. More recent studies have
stated that up to 25% of patients hospitalized with HF are readmitted within 30 days70 71. As a result,
specific interventions are needed to curtail readmissions in this population.
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The one-year survival rate has been estimated at 80–90% in mild to moderate heart failure72 and 50–
60% in severe heart failure73, which is more malignant than breast, bowel, bladder, prostate and ovarian
cancer74. Heart failure is also associated with high morbidity and is the most common discharge
diagnosis for patients over 65 years of age, in many industrialized countries75 76. Issues and barriers in
the management of patients with heart failure were reviewed in various studies that look at improving
overall outcomes. A subset of the issues and barriers identified include, but are not limited to, less than
optimal treatment77, and the often insufficient education given to patients with heart failure in order to
teach self-care.78 It has also been shown in studies from different settings that non-compliance with
medications, diet and/or symptom monitoring have been associated with 15–64% of the hospital
readmissions79 80 81. There is an emerging model that focuses on treating high risk populations (primarily
heart failure patients) in an outpatient, nurse driven setting.
Programs that are targeted to preventing readmission are frequently referred to as ‘transitional care
interventions’, which is descriptive of how they bridge the inpatient care and outpatient environment
(including a patient’s return home). These transitional care interventions have been defined as “a broad
range of time-limited services designed to ensure health care continuity, avoid preventable poor
outcomes among at-risk populations, and promote the safe and timely transfer of patients from one
level of care to another or from one type of setting to another”82. Utilizing an outpatient disease
management clinic is one strategy that is being investigated as a part of a more comprehensive
approach to transitional care interventions.
Previous studies have documented that nurse-led disease management programs for heart failure
patients, including early follow-up after hospitalization and in depth patient education, have the
potential to prolong event-free survival83,84 decrease the number of hospital admissions85 86 87 88 as well
as improve compliance89, self-care behavior90, and quality of life91.
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This paper attempts to contribute to this evidence base regarding nurse and nurse practitioner-led
disease management clinics for heart failure patients as a component of a successful transitional care
strategy. This paper describes the development of a disease management clinic implemented by the
hospital to provide outpatient services to low income and underserved populations that ordinarily
would have had no other access to follow-up care. The program was measured by degree of success in
enrolling patients in the clinic and reduced readmissions to the hospital of the enrolled population.
Community Needs Assessment
The service region of the disease management clinic consists of six counties in southeast Texas:
Jefferson, Orange, Hardin, Jasper, Tyler and Newton. The entire service area population totals 539,681.
This is an increase of 4,941 over the 2010 census, and is projected to grow to 557,125 by 2018, an
increase of 3.2%. The demographics in the service region vary greatly by county. Economic growth has
remained relative flat for a number of years. Jefferson County is highly industrialized and has pockets of
urban poverty in both of the major cities: Beaumont and Port Arthur. In contrast, the rest of the service
region is primarily rural although many residents are as economically disadvantaged as those in the
cities. Beaumont, located in Jefferson County is the major medical hub for the region.
Jefferson County, Texas ranks 205 of 221 Counties in Health Outcomes, 209 in Health Behaviors, and 218
in Physical Environment. Age-Adjusted Mortality Rates per 100,000 by County are significantly higher in
the service area for the following: Ischemic Heart Disease; Stroke; and Congestive Heart Failure. There
are also significantly higher rates of diabetes, high cholesterol and high blood pressure. Economics,
culture and physical environment are all causal factors in the poor health status of those living in the
region. The County is a Medically Underserved Area as designated by the Health Resource & Services
Administration, coupled with a shortage of primary care and specialty physicians. Together these factors
have created a cycle in which chronic diseases go undiagnosed and or untreated until the patient is so ill
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that they are frequently presenting to the emergency department for primary treatment, the most
expensive setting to receive care.
Higher than average Medicare expenditures (measured by the Medicare spending per beneficiary) and
preventable hospitalization rates in Southeast Texas and the shortage of primary care providers reflect
the health challenges faced by residents in the identified service area. For example, 26.5% of Medicare
Part A, Heart Failure patients are readmitted to the study hospital within 30 days of discharge. This rate
is consistent with others throughout the region. Southeast Texas has one of the highest rates of
unadjusted expenditures for non-capitated Medicare in the US. Differences in the amount and types of
care used, rather than population characteristics and prices, are responsible for much of the variation in
spending. In addition, the findings show that people in higher spending areas do not receive better care.
The area’s higher than expected morbidity and mortality rates were key drivers in the decision to create
new lower cost targeted resources for the community. Those over 65 years of age are the fastest
growing segment of the population, and represent 13.4% of the population in the primary service area.
The prevalence of chronic conditions such as Ischemic Heart Disease (42.2%), Diabetes (30.7%), Chronic
Obstructive Pulmonary Disease (13.3%), and Heart Failure (23.5%) in this service area are above national
Medicare averages. Hospital 30 day mortality rates for heart failure patients are 12.1% compared to
10.9% nationally92. The CHF admission rate is higher for both the 65-74 and the 75+ age groups than
national averages93. County residents have a higher rate of adult-smoking, obesity, physical inactivity,
and poor physical health days than the statewide average, each of which puts residents at risk for
common chronic diseases94.
There are also disturbing trends that relate to the future of Southeast Texas. According to the KIDS
Count Data Center, 33.5% of the children in Jefferson County live in poverty, and 32% receive social
security income as well as Food Stamps. Unemployment has historically been over 10%. The ethnic
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breakdown for children is as follows: 32% Anglo, 38% African American, 22% Hispanic, and
Other/Unknown 8%. The service area also has 26% of its population under the age of 1895.
The target population for this project is residents of the disease management catchment area who
suffer from a primary or secondary congestive heart failure diagnosis. It is estimated that among the
10.9% of the catchment area patients who suffer from congestive heart failure, 39% are Medicaid
insured or uninsured.
As previously noted, economics, culture, and history are all causal factors in the poor health outcomes
of the service region. The area has a poverty rate of 22.6% and an uninsured rate of 25.2%—both of
which are higher than the respective state and national rates96. There is no county hospital district and
only one Federally Qualified Health Center serving the region. The region has been continuously served
by two primary, religious-sponsored, not-for-profit hospitals for over 100 years. Texas is one of the most
litigious areas in the United States, and for many years recruiting and retaining physicians was a major
challenge. The lack of primary care due to recruitment challenges has created a cycle in which chronic
diseases go undiagnosed and/or untreated in the catchment area.
Study Methodology
Previous studies reviewed during the development of this clinic structure primarily focused on some
element of patient education. In most, education or self-care training began prior to discharge and was
reinforced after discharge, but some did not include an educational component before discharge97 98 99
100 101 102. All previously published studies reviewed had similar basic components including education or
training and focused on self-care, diet, medications, and early recognition of symptoms.103 104 105 106 107
108. The disease management clinic was developed to support a similar model based on patient
education.
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The current clinic standards/ practice guidelines are based on the 2009 focused update: ACCF/AHA
Guidelines for the Management of Heart Failure in Adults. The department goals are as follows:
• Provide education to patients about their disease process, the signs and symptoms of their
disease, and titrate medications as needed for optimum health.
• Identify appropriate patients for cardiac rehabilitation and facilitate referral.
• Coordinate care with referring physicians.
• Identify and address any psychosocial barriers to care.
• Maintain adequate resource requirements to meet program, staff, and patient needs.
• Participate in grant activities as available.
• Educate community about heart failure through community outreach programs.
Based on the community needs assessment of the catchment area, an outpatient-based disease
management clinic was established in 2014 to help address the underserved needs. This outpatient-
based disease management clinic was developed and implemented in conjunction with a medium sized
(<250 bed), non-academic rural hospital in the heart of Southeast Texas. The targeted patient
population for program participants were patients with a primary or secondary diagnosis of HF,
including medically underserved enrollees of all ages. These patients were identified through referrals
from ED visits and hospitalizations, as well as direct referrals from both primary care and specialty
providers. Patients identified as high risk for hospital admission/readmission and that could benefit from
intensive care coordination were the first patients enrolled in 2014.
The goals of the disease management clinic are to provide education, counseling, and medication
titration of heart failure patients referred to the clinic. Research nationally demonstrates that heart
failure clinics can decrease readmissions, improve patient outcomes and decrease mortality. The
disease management clinic was established on the foundation that patient education, including cultural
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and spiritual components, is an integral component of the medical care of heart failure patients and
their families. This program is provided in a competent and compassionate manner and in keeping with
the mission of the hospital. In order to address the identified socio-economic challenges of the
identified patient population, the clinic provided scales and sphygmomanometers for measurement and
monitoring of weight and blood pressures, respectively, at home, as well as medication samples and
prescription discount cards when needed.
The disease management clinic is a patient-centered practice which focuses on ongoing learning. Use of
a broad range of existing community resources, staff trained to connect with these services, and the
provision of follow-up care have empowered patients to access the most appropriate and cost-effective
resources for their conditions. As part of the mission of the disease management clinic, all individuals
and departments adhere to the ethical principles and policies outlined by the hospital, including the
Code of Ethics, Associate Covenant, and Standards for Catholic Identity. Specific to the disease
management clinic, all ancillary services offered in the clinic (e.g., social work, financial counseling,
dietician services) are available across all types of patients, regardless of socioeconomic status, race,
religion, age, sexual preference or gender.
The disease management clinic is designed for all patients with heart failure, regardless of acuity. While
all patients with HF are accepted, research indicates that patient acuity levels are related to a patient’s
readiness to learn among all classes of HF patients109. For example, a study of patients with Class II
Heart Failure shows they have the best readiness to learn. The clinic provides education and support to
outpatient of all ages, economic status or culture. Family members and/or significant others are
encouraged to participate in the educational process. Patients are screened for the clinic and then a
request is made to the physician (PCP, hospitalist or cardiologist as appropriate) for a clinic referral.
Once patients are referred to the disease management clinic the clinic nurse (an RN) makes an
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appointment for the patient, answers any questions for the patient about the program, and provides the
patient and spouse/caregiver an information packet.
The clinic visit includes completion of an extensive questionnaire, screening, assessment by a nurse
practitioner, and medication reconciliation. Patients are required to sign a contract about their
responsibilities and the clinic indicates theirs. Follow up visits may include seeing a dietitian, a Licensed
Clinical Social worker, and/or a pharmacist as needed. The visits consist of an initial assessment of the
patient's current understanding of the signs and symptoms of the disease process, knowledge of their
medications, barriers to compliance including financial, social, and/or cultural. Upon completion of the
assessment, areas of concern are discussed with the patient and/or significant other to determine goals.
Education is provided individually to patients, according to their physical and/or emotional status. A
record of the education is documented in the medical record. Ongoing education is provided to the
nursing staff as well as to the patient and family. Education is provided and conducted at the clinic site.
The length of education depends on the patient’s condition, physical limitations and emotional status.
During the assessment and education processes, the provider may interact with many departments
within the hospital setting, such as Social Services, Spiritual Care, Pharmacy, Nutrition and Foods
Services, Case Management, Business Services, and various departments and levels within Nursing
Services. Interaction may also occur with various community resources, such as the American Heart
Association, Heart Failure Society of America, or the American Association of Heart Failure Nurses as
well as identifying resources necessary to fulfill medical/educational needs.
The disease management clinic is staffed with an RN, nurse practitioner, and a dietitian. The RN and
Nurse Practitioner both maintain Heart Failure Certification through continuing education or testing
every 3 years to maintain certification. Eligibility to take the examination is based upon the American
Association of Heart Failure Nurses. The dietitian is part of the Dietitian Department of the hospital.
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Ongoing staff education is offered on-line through the hospital’s Education Resource Center. Associates
must maintain continuing education credits as mandated by licensure/association standards. The clinic
also includes the services of disease management navigators, licensed clinical social workers, financial
counselors, exercise physiologists, CNAs, and respiratory therapists. The services of the mid-level
providers support the work of the specialists to empower high-risk individuals to take charge of their
own health and to access the appropriate level of care.
The disease management clinic serves a group of patients with chronic illness in a resource-rich
ambulatory setting supported by multidisciplinary teams. The disease management clinic team provides
improved access to health and community resources, education, and self-management resources.
The disease management clinic’s hours are Monday through Friday from 9am-5pm. Most referrals to
date have come from the inpatient setting during the patient’s index admission. A list of potential
referral eligible patients is reviewed by clinic staff each day. If the patient has already been discharged,
attempts are made to call the patient at home and schedule an appointment as an outpatient.
Roles of Clinic Members
 CNA: Greet patients, obtain weight & vital signs, draw labs, perform EKG, schedule & confirm
appointments.
 LVN: chief complaint, reconcile medication list, administer medications.
 RN: phone assessments, case management duties, prescription refills, coordinate care after
every clinic visit with cardiologist and other physicians as needed, triage incoming patient calls,
calling physician offices to update with concerns and answering patient questions. (added
position)
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 HF Nurse Navigator: visits cardiologists’ and PCPs’ offices to discuss referral processes and
communication. Encourages physicians to refer patients and determine if there are areas of
improvement for the clinic.
The multi-disciplinary care management approach within the community provides support, training,
and interventions necessary for patients to manage their chronic conditions outside of the inpatient
setting.
Study Results
As of January 2018, the disease management clinic has been operational for four years, enrolling a total
of 491 unique patients into the program. A summary of the patient characteristics can be found in Table
1.
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Table 1: Demographic Breakdown of Disease Management Clinic Participants
As the program’s scope and outreach continued to expand, total enrollment also grew (Table 2).
Expansion of the clinic volumes was tied to better alignment with local cardiology groups as well as the
employed Hospitalist group, who are contracted to see unassigned patients – many of whom were the









Table 2: New Clinic Enrollees by Year
Sex Patients % of Total Patients % of Total Patients % of Total Patients % of Total Patients % of Total
Female 41 49.4% 39 36.1% 58 47.2% 80 45.2% 218 44.4%
Male 42 50.6% 69 63.9% 65 52.8% 97 54.8% 273 55.6%
Grand Total 83 100.0% 108 100.0% 123 100.0% 177 100.0% 491 100.0%
Marital Status
Divorced 8 9.6% 15 13.9% 23 18.7% 29 16.4% 75 15.3%
Legally Separated 2 2.4% 2 1.9% 4 3.3% 3 1.7% 11 2.2%
Married 33 39.8% 37 34.3% 38 30.9% 51 28.8% 159 32.4%
Single 16 19.3% 31 28.7% 40 32.5% 82 46.3% 169 34.4%
Unknown 0 0.0% 1 0.9% 1 0.8% 1 0.6% 3 0.6%
Widow/Widower 24 28.9% 22 20.4% 17 13.8% 11 6.2% 74 15.1%
Grand Total 83 100.0% 108 100.0% 123 100.0% 177 100.0% 491 100.0%
Race
African American/Black 24 28.9% 42 38.9% 45 36.6% 76 42.9% 187 38.1%
Asian/Eastern Indian 0 0.0% 0 0.0% 1 0.8% 0 0.0% 1 0.2%
American Indian 1 1.2% 0 0.0% 0 0.0% 0 0.0% 1 0.2%
Peoples-Euro/MidEast 57 68.7% 65 60.2% 74 60.2% 101 57.1% 297 60.5%
Unknown 1 1.2% 1 0.9% 3 2.4% 0 0.0% 5 1.0%
Grand Total 83 100.0% 108 100.0% 123 100.0% 177 100.0% 491 100.0%
Age
<40 0 0.0% 6 5.6% 19 15.4% 32 18.1% 57 11.6%
40-49 11 13.3% 13 12.0% 24 19.5% 42 23.7% 90 18.3%
50-59 8 9.6% 28 25.9% 26 21.1% 51 28.8% 113 23.0%
60-69 18 21.7% 21 19.4% 38 30.9% 38 21.5% 115 23.4%
70-79 20 24.1% 27 25.0% 10 8.1% 9 5.1% 66 13.4%
80-89 23 27.7% 12 11.1% 6 4.9% 5 2.8% 46 9.4%
90+ 3 3.6% 1 0.9% 0 0.0% 0 0.0% 4 0.8%
Grand Total 83 100.0% 108 100.0% 123 100.0% 177 100.0% 491 100.0%
2014 2015 2016 2017 Grand Total
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Of the unique clinic enrollees over the previous 4 years, nearly half (50.3%) are uninsured. Of the
remaining, approximately one-third (30.3%) had private insurance and 19.3% had either Medicare or








Private Insurance 149 30.3%
Self-Pay/
Uninsured 247 50.3%
Total Patients 491 100.0%
Table 3: Payor Source by Patient
Clinic patient characteristics by disease group can be seen in Table 4. Note that patients may present
with multiple co-morbid disease states. As noted, 31% of patients treated for COPD, HF or HTN had
diabetes as a comorbid condition. Patients with existing hypertension were also tracked beginning in
2017 as a way to capture additional comorbid disease states of the patient population.
Primary or Secondary Disease





Separately in 2017) 31 6.3%
All Patients
491
*Note that patients may present with
multiple disease processes
Table 4: Disease Process of Clinic Patients
Once the patients enrolled in the program, the majority continued seeking treatment with the clinic at






54.6% Multiple Visits (2 or more)
31.1% 5 or More Visits
Table 5: Visit Frequency of Clinic Patient Population
When looking at the overall CHF patient discharges compared to enrolled HF clinic patients, patients
who are enrolled in the clinic appear less likely to experience a 30-day (all cause) readmission. Clinic
enrollment occurs following a referral to the disease management clinic from the inpatient stay,
although the clinic will also accept referrals directly from a referring physician’s office. Over the
previous 4 years, only 7.9% of CHF disease management patients experienced a readmission, compared
to 15.8% of the general CHF population not enrolled in the clinic.
Year over year improvements in the HF clinic readmission rates may indicate the cumulative success of
the educational interventions, overall clinic effectiveness and ability of the clinic staff to effect
meaningful differences in the behaviors of the enrolled population. As seen in Table 6, as clinic
enrollment has increased, HF readmissions have decreased. HF specific readmissions in the hospital
showed modest declines over the study time period. This may be due to the proportion of the overall
hospital HF population that is enrolled in the clinic. No changes in patient characteristics were known to




















2014 388 63 16.2% 83 10 12.0%
2015 454 72 15.9% 108 11 10.2%
2016 534 83 15.5% 123 11 8.9%
2017 736 115 15.6% 177 7 4.0%
Total 2112 333 15.8% 491 39 7.9%
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Table 6: Readmission Rates by Hospital and Clinic Enrollees
Commentary
Limitations
The nature of this study was observational, and was not the goal of this paper to include a comparison
group for analysis. As such, a comparison group with similar patient characteristics, severity and
hospital discharge profiles was not included; rather the purpose of this paper was to discuss the
components of a disease management clinic that was shown to be effective in bridging care for the
targeted population.
The clinic is funded by the Texas Medicaid 1115 Waiver (DSRIP). In December 2011 Texas received
approval from CMS for a waiver to upcoming changes in federal support for state Medicaid programs. A
new 1115 waiver was approved in December, 2017 and will continue funding through 2022. Under the
waiver, hospitals are encouraged to form regional health partnerships that support more localized
health care solutions in order to qualify for incentive payments. The five year waiver allows Texas to
continue receiving federal funds while allowing expansion of managed care. Hospitals providing care to
uninsured patients in the form of uncompensated care will continue to receive this funding, however
long term viability will need to be established in lieu of additional and future government support.
Discussion
The current state of the healthcare system can no longer sustain a volume based mentality but rather
must focus on a value based approach to reduce costs, provide care in the most appropriate setting
possible, and reward providers for improved outcomes. As such, the disease management clinic is being
advanced as an effective intervention to reduce admissions among high risk and vulnerable populations
and has significant value on several fronts. Nearly 1 in 6 patients that are diagnosed with heart failure
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are readmitted back into the hospital within 30 days. This high HF readmission rate speaks to a current
system designed to treat illness but lacking the infrastructure or focus to prevent readmissions and
provide for preventive care. By engaging in a focused effort to reduce this problem in our community, a
more rational use of scarce resources will be created thereby meeting the goals of the IHI Triple Aim
initiative and the core values of the organization.
As inpatient demand is often outpacing bed and/or staff availability in Southeast Texas, finding the
appropriate setting to care for patients with chronic conditions becomes more and more important.
CMS pressure to reduce readmissions by penalizing hospitals with higher average readmissions further
emphasizes the importance of platforms like this care transition program. The disease management
clinic was designed as a bridging therapy between the hospital setting and the patient’s next level of
care (typically the PCP or Cardiologist). The clinic worked with patients and local physician groups to
find permanent PCPs for those patients who did not have a continuous source of primary care.
The 2013 American Heart Association/American College of Cardiology (AHA/ACC) Heart Failure
guidelines addressed post discharge HF specific interventions. These guidelines focus on the importance
of optimizing HF pharmacotherapy before discharge, providing HF education before discharge (including
self-care management), and addressing barriers to care among other factors. This included a follow-up
visit within 7 to 14 days of discharge or a telephone follow-up within 3 days of discharge110. The
AHA/ACC guidelines also recommend initiating multidisciplinary HF disease management programs for
patients at high risk for readmission111. However, the AHA/ACC did not provide definitive guidance on
the recommended components of transitional care interventions aimed at preventing readmissions for
patients with HF.
The care transition program described here includes all five of these elements that are outlined by the
AHA/ACC. Initial success of this program demonstrates the potential benefit to scaling this effort to
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reach a larger percentage of the CHF discharged population. In addition, future endeavors may expand
to other chronic care disease states beyond CHF.
Continued success of the clinic will require alignment with local cardiovascular surgeons for post CABG
patients to begin utilizing the disease management clinic for follow-up visits (currently not utilized),
Ensuring sustainability for the clinic also will require increasing the overall referral base to the clinic for
non-heart failure specific DRGs (currently not receiving referrals outside HF and minimal COPD/ diabetes
education), obtaining grant funding through the community based need organizations to align
initiatives, and contracting with a local home health agency to conduct care transition visits.
This program serves as further evidence of a successful demonstration for leveraging a care transition
program to bridge the gap between discharge and the next level of care through an outpatient disease
management program. Further attention should be given to scaling the program and capturing a larger
share of the overall hospital’s HF population.
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Manuscript 3: Chronic Care Management: A Home-




Chronic care management programs have become prevalent as a component of population health
strategies aimed at reducing inpatient overutilization. Efforts by CMS to penalize hospitals with high
readmission rates coupled with limited inpatient bed and staff availability have placed even more
pressure on health systems to appropriately manage patients with chronic conditions in the most cost-
effective setting. As a result, health care institutions are shifting focus to transitions of care and
outpatient management programs. This paper will describe the development of a care transition
program utilizing a post-discharge in home visit with additional telephone support implemented at a
medium sized (<250 bed) rural hospital in Southeast Texas. Initial results of this program demonstrate
the potential of home-based interventions as a successful approach to a hospital’s overall readmission
reduction strategy.
Background
The Affordable Care Act of 2010 established the Hospital Value Based Purchasing (VBP) Program, which
affects payment for inpatient stays based on relative performance across the county. In subsequent
years CMS finalized the policies that would establish the program to penalize hospitals with high
readmission rates of patients with specific conditions including heart failure (HF), patients admitted for
an acute exacerbation of chronic obstructive pulmonary disease (COPD), acute myocardial infarction
(AMI), and pneumonia (PN)112. The VBP program has had far reaching effects. Medicare under the
Hospital Readmissions Reduction Program will reduce reimbursement for 2,573 hospitals for fiscal year
(FY) 2018, according to CMS data113.
Heart failure has been a focus of the readmission reduction penalty program since its inception largely
due to the net potential of that patient population. A previous analysis of Medicare claims data from
2007 to 2009 found that 35% of readmissions within 30 days were for HF114. More recent studies have
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stated that up to 25% of patients hospitalized with HF are readmitted within 30 days115 116. As a result,
tailored interventions are needed to curtail readmissions in this population.
Programs that are targeted to preventing readmission are frequently referred to as ‘transitional care
interventions’, describing how they bridge the inpatient care and outpatient environment (including a
patient’s return home). These transitional care interventions have been defined as “a broad range of
time-limited services designed to ensure health care continuity, avoid preventable poor outcomes
among at-risk populations, and promote the safe and timely transfer of patients from one level of care
to another or from one type of setting to another”117.
There currently exists limited evidence on the effectiveness of home-visit based programs in reducing
all-cause 30 day (unplanned) readmissions. However, the meta-analysis study conducted by the
Effective Heath Care Program, (which included nine trials) found that patients receiving home visits had
a significantly reduced risk of all-cause readmission over 3 to 6 months (RR, 0.75; 95% CI, 0.66 to
0.86)118. At 3 months, one trial by Rich et al., included in the meta-analysis (N=282) found that patients
receiving home visits had a significantly lower risk of HF-specific readmissions than controls (RR, 0.51;
95% CI, 0.31 to 0.82)119. Another trial by Kimmelstiel et al., (N=200) reported that patients receiving
home visits had significantly fewer total HF specific readmissions than did patients receiving usual care
(RR, 0.54; p<0.001)120. The meta-analysis also found (in eight trials) no difference in the relative risk of
all-cause readmission between patients receiving telephone based reinforcement and those receiving
usual care (RR, 0.92; 95% CI, 0.77 to 1.10) 121.
This paper attempts to contribute to the evidence related to the effectiveness of home-visit based
programs in reducing all cause unplanned readmissions in the targeted population. This paper also
seeks to demonstrate that a home-visit based intervention can be an effective strategy further
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supplemented by telephone support as a means to approach reduction in hospital 30-day all cause
readmissions.
Study Methodology
Previous studies reviewed in the development of this program, which focused on telephone based
reinforcement as a supplemental component in addition to the in-home visit, included patient education
as a major component. In some of the reviewed studies, education or self-care training began prior to
discharge and was reinforced after discharge during telephone follow-up, while others did not include
an educational component before discharge122 123 124 125 126 127. Most reviewed studies included an
option for a patient-initiated call as support for questions that arose after discharge. Previously
published studies involving home-visit based follow up all had the following elements - education or
training focused on self-care, diet, medications, and early recognition of symptoms.128 129 130 131 132 133.
Based on the review of successful previous studies, a home-based transitional care program was
developed and implemented at a medium sized (<250 bed) non-academic rural hospital in Southeast
Texas. The targeted patient population for program participants included traditional English speaking
Medicare enrollees (aged 65 and older) who were admitted to the hospital between July and December,
2017 with a primary diagnosis of heart failure. A visual depiction of the program touchpoints can be
found in Figure 1.
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Figure 1
During the initial hospital admission, patients are assessed by the hospital’s heart failure clinician
(registered nurse) to determine if the patient clinically meets initial program criteria and confirm
underlying heart failure. The hospital’s heart failure clinician is focused on educating patients within the
hospital for new onset CHF. This position was previously referred to as the “Core Measures Nurse” and
ensured the hospital was compliant with the CMS core measures pertaining to heart failure (e.g.,
ensuring discharge instructions were included in the record, systolic function was measured and
documented in the record, patient was on Beta-blockers, etc.). Currently the role covers primarily
patient education. The heart failure clinician reviews the patient’s pertinent lab work (BNP), physician
documentation, weight increase, chest x-ray to assess any pulmonary edema or vascular congestion and
any history of failed outpatient diuretic changes. Based on this review the heart failure clinician confirms
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that the patient is a candidate, is being discharged directly home, and then notifies the care transition
coordinator (also a registered nurse) of a new patient to the program. Patients being discharged to a
skilled nursing facility, nursing home, acute rehab, or other post-acute non-home based setting were
excluded from participating in the program. From 2014-2017 HF discharge dispositions for the study
hospital were as follows: Home self-care (53.7%), home health (23.2%), SNF (15.8%), long term care
(4.4%), rehab (2.9%). Since the goal of the program was to bridge services between discharge and the
next level of care (PCP or Cardiology visit), patients discharged home to self-care were felt to be of
higher risk of readmission. Data from the study hospital showed that patients 65 years and older that
were discharged home (to self-care) had a 13.5% 30 day all-cause readmission rate.
The care transition coordinator visits with the patient prior to discharge and presents the patient with a
welcoming letter that includes a section titled “What does this mean for you?”. The letter explains that
the patient will be: 1) visited by a Registered Nurse to review their medications, perform a clinical
assessment, and answer any health-related questions they may have; 2) that a home visit will occur 1-2
days after discharge; 3) that the patient will be receiving a telephone call to check in with them over the
next 30 days; and, 4) that the patient will have access to a “Call Us First Program” where a clinician is
available 24 hours a day, 7 days a week to walk through any health related concerns or questions they
may have for 30 days following discharge from the hospital. Also included in the letter is language
stating that the program is “intended to improve your quality of care when you get home and is at no
cost to you or your insurance”. This language was added to mitigate potential patients from opting out
of the program for fear of cost to themselves or cost to their insurance. Prior to discharge the care
transition coordinator distributes a ‘personal health record’ booklet and reviews the following checklist
with the patient:
o I have the name and phone number of a person to contact if I have questions.
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o I understand where I am going and what will happen next in my recovery.
o I understand what my medications are, how to obtain them and take them.
o I understand the potential side effects and symptoms of my medications and whom to call if I
experience any.
o My doctor or nurse has answered my most important questions prior to leaving.
o I have a follow-up appointment scheduled with my doctor and transportation has been
coordinated.
o I have the necessary equipment ordered and ready to be delivered.
Although many of the items in the booklet are yes/ no responses, the purpose of reviewing the
information is to further engage the patient in their personal health. The care transition coordinator
then completes the following specific assessment to determine the patient’s readiness to transition
home and helps guide any tailored interventions needed.
Care Transition Risk Assessment Tool Suspected Barriers to Transition Home
Age 80 or older May not have transportation to appointments
Moderate to severe functional deficits May be unable to afford medications
History of mental/emotional illness May be unable to afford food or other basic items
Four or more coexisting health conditions Home environment may be unsuitable/unsafe
Six or more prescribed medications Lives alone
High risk medications* Deficits in patient understanding (health literacy)
Two or more hospitalizations in the last 6 months Lives with someone who is unable or unlikely to assist
Hospitalization in the past 30 days Language barrier
History of non-adherence to medical regimen Other:
* High Risk Meds include: insulin, narcotics/opiates, anticoagulants, inotropics, chemo drugs, lithium, clozapine, epinephrine, propranolol,
digoxin/lanoxin.
Preliminary Medication Reconciliation
Obtained list of medications patient was taking prior to hospitalization/facility stay
Compared to MAR and/or discharge medication list
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Communicated with facility and ensured any discrepancies were intentional
Communicated with facility and ensured any potential clinically significant issues were resolved
Ensured patient/caregiver had a plan to obtain all prescribed medications following discharge
Following discharge, the care transition coordinator conducts an initial phone call with the patient
within 24 hours. The care transition coordinator introduces the concept of this call while the patient is
still admitted to the hospital, and in conjunction with the hospital’s heart failure clinician begins to
educate the patient and their family on the disease process. The care transition coordinator (if allowed)
also enters the phone number of the call center from which the call will originate into the patient’s
phone, so that the patient will recognize the number when it occurs. The focus of this call is on
medication management and ensuring that the patient remembers their next level of care appointment
(cardiologist, primary care physician, etc.), which was scheduled by case management prior to discharge.
The date and exact time of the upcoming in-home visit is also confirmed with the patient. A reminder
phone call is also placed to the patient the evening before the initial in-home visit.
During the in-home visit, the registered nurse completes an in depth screening that covers both medical
and social barriers to the patient’s wellness. The care transition coordinators operate in conjunction
with an outpatient disease management clinic that is a department of the hospital. As part of the
program, a protocol was developed to clinically guide the in-home visit and direct follow-up care
coordination with the disease management clinic as needed. The in-home visit consists of the following
elements, which were developed and written as a part of the patient’s care transition protocol: personal
health goal (purpose), clinical risk factors, in-home based visit assessment and educational components
to review.
The purpose of the in-home visit is to assess clinical stability of the patient at home following post-acute
care and to promote patient engagement, self-management and support post hospital discharge.
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An accurate patient weight will be assessed in home at time of visit to evaluate volume status for signs
and symptoms of heart failure exacerbation.
• For patients with a weight gain of 2-5 pounds from in-hospital baseline:
o Contact physician of record for further instructions
• For patients with a weight gain of >5 pounds from in-hospital baseline:
o Notify Heart Failure Disease Management Clinic for potential nurse practitioner
evaluation (at the disease management clinic)
• For any of the following vital signs outside of noted parameters, the physician of record will be
contacted. If physician cannot be reached, the Disease Management Clinic will be contacted for
potential Nurse Practitioner evaluation:
o Oxygen saturation 90% or less on room air
o Blood pressure systolic change of >30 mmHg from baseline
o Heart rate >120 bpm
While in the home, the care transition coordinator (RN) will do the following:
• Conduct an onsite patient assessment to ensure safe transition to home
• Assess presence of barriers to care (e.g., cognitive, environmental, social, transportation)
• Perform medication reconciliation and risk assessment
• Review with patient all appointments with PCP and Cardiologist and ensure patient can attend
visits
• Coordinate care with patient, family, hospital and PCP as appropriate
• Provide a food inventory/ nutrition screen as indicated
• Conduct community health needs screening
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Also during the in-home visit, the following educational elements are reinforced with the patient:
• Discuss the concept of the transition program including personal goals/behavior modifications
• Education on recognition of worsening signs/symptoms of their disease state
• Educate on medications including purpose and side effects and importance of adherence
• Reinforce proper monitoring of daily weight (e.g. first thing in am after voiding)
• Review and educate on comorbidities (COPD, Diabetes, etc.)
Education in the home continues the concepts that were reviewed by the Hospital’s heart failure
clinician prior to discharge. Patients are further instructed to call if any of the following issues arise:
• Swelling in ankles, legs, or abdomen that has become worse
• Shortness of breath that has become worse
• Extreme fatigue or decreased ability to carry out daily activities
• A respiratory infection or a cough that has become worse or won’t go away
• Frequent chest pain or discomfort on exertion
• Rapid, irregular or difficulty breathing while resting or carrying out regular activities
• Dizziness, lightheadedness or restlessness
After that initial in-home visit, the care management call center contacts the patient weekly for the next
three weeks. Patients are also encouraged to utilize the 24/7 telephone support for any questions or
medical issues that arise.
Study Results
As of December 2017, the care transition in-home program at the Southeast Texas hospital under study
has been operational for 6 months. During that period, 67 patients were enrolled in the program
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described in the study methodology section. A summary of patient age and gender is provided in Table






65-69 41.8% 28 19 9
70-74 13.4% 9 5 4
75-79 20.9% 14 8 6
80-84 9.0% 6 4 2
85-89 9.0% 6 4 2
90-94 4.5% 3 2 1
95+ 1.5% 1 0 1
Total 100.0% 67 42 25
Table 1: Age Breakdown by Study Participants
As described in Table 2, the majority of patients enrolled were primary CHF patients (83.6%); 16.4% of
the enrollees had a primary diagnosis of COPD, however all patients had an accompanying secondary










Table 2: Chief Complaint of Study Participants
Table 3 details the number of patients enrolled by month since the inception of the program in July,
2017. Enrollments during the months of September and October were impacted by the effects of













Table 3: Discharge Month of Study Participants
As reflected in Table 4, the majority (59.8%) of enrolled patients were seen on the day of discharge or
the day immediately prior to discharge. By design, the initial in-hospital visit was conducted as close to
discharge as possible to increase the likelihood of patient adherence to the program and likelihood that
the education delivered would be enduring. Early intervention was thought to be key in helping
reinforce health habits and also make the transition into the home.






Day of Discharge 20 29.9%
Day Prior to Discharge 20 29.9%
Two Days Prior to Discharge 11 16.4%
Three or More Days Prior to Discharge 16 23.9%
Total 67 100.0%
Table 4: Care Transition Coordinator In-hospital Visit Day of Visit
All patients enrolled in the program had the initial phone call conducted within the first 4 days following
discharge. The majority (76.1%) were conducted within 24 hours of discharge (Table 5).
Initial Phone Call Conducted
(By Care Transition Coordinator) No. of Patients % of Total
Within 24 Hours of discharge 51 76.1%
Within 48 Hours of Discharge 4 6.0%
Within 72 Hours of Discharge 10 14.9%
Within 96 Hours of Discharge 2 3.0%
Total 67 100.0%
Table 5: Study Participant Initial Phone Call Timing
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Based on the data presented in Table 6, following the initial post-discharge follow-up phone call, 54
patients (80.6%) successfully completed the in-home visit. Of the 13 patients who did not have an in-
home care transition visit, 8 patients (61.5%) declined to continue in the program, 2 patients (15.4%)
were admitted to a traditional home health program (and thus were disqualified from the care
transition program), 1 patient (7.7%) was evacuated due to Hurricane Harvey, 1 patient (7.7%) was
unable to be reached once in home, and 1 patient (7.7%) was lost to follow-up. Later initial visits (i.e.
the longer the time between discharge and the initial in-home visit) were often seen associated with
Friday/weekend discharges, and holiday (Thanksgiving) schedules.
These touchpoints (including the in-hospital visit introduction, initial phone call and in-home visit) with
the patient were designed to: 1) promote patient engagement, self-management and support to
encourage the patient to continue communication with their care team after hospital discharge
(transition to the community); 2) assure communication between the patient and PCP/Cardiologist for
appropriate patient support; 3) ensure the patient has access to any needed community and caregiving
services; 4) conduct ongoing and continual medication reconciliation and reinforce the importance of
medication adherence.
Initial Home Visit Date Post-discharge No. Patients % of Total
Within 72 Hours of Discharge 18 33.3%
Within 7 days of Discharge 22 40.7%
Within 14 days of Discharge 11 20.4%
Within 21 days of Discharge 3 5.6%
Total 54 100.0%
Table 6: Study Participant Initial Home Visit Timing
Based on the data presented in Table 7, the vast majority (88.2%) of the call center initiated calls
occurred within 7 days of discharge. Three additional patients were lost to follow-up at this stage.
Subsequent attempts to reach the remaining patients by phone became less successful as the program
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continued. Patients that did not have all three care transition coordinator calls had multiple attempts to
reach the individual. Whether the phone calls were simply unsuccessful in reaching the patient or the
patient consciously chose not to continue engagement in the program is not known.
The telephone based reinforcement is similar in nature to educational based initiatives, and primarily
serves to check-in on patients following transition to home. These programs historically have focused
on patient monitoring and/or self-care management (or various combinations) after discharge in a
structured format through the use of decision support software.
Follow-up Phone Call #1 Post-Discharge
(By Call Center)
No. Patients % of Total
Within 7 days 45 88.2%
Within 14 days 6 11.8%
Total 51 100.0%
Table 7: Follow-up Phone Call #1 Timing of Study Participants
Follow-up Phone Call #2 Following Initial
CTC Call (By Call Center)
No. Patients % of Total
Within 7 days 37 84.09%
Within 14 days 7 15.91%
Total 44 100.00%
Table 8: Follow-up Phone Call #2 Timing of Study Participants
Follow-up Phone Call #3 Following
Second CTC Call (By Call Center)
No. Patients % of Total
Within 7 days 25 71.43%
Within 14 days 10 28.57%
Total 35 100.00%
Table 9: Follow-up Phone Call #3 Timing of Study Participants
Although not all patients were able to complete all three CTC follow-up calls (68% successfully
completed all three calls), all 67 patients initially enrolled in the program successfully made it to their
next level of care visit (PCP, Cardiology, etc.) (Table 10). This element was a major milestone of the
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program; that is, keeping patients healthy until their next level of care. Most importantly, none of the
67 patients enrolled in the program were readmitted to the hospital within 30 days of discharge.
Although not all patients had every touchpoint (initial call, in home visit, plus 3 follow-up calls), all were
included in the review as education began in the inpatient setting and focused on staying healthy until
the next level of care appointment. For that reason, they were included in the final count of patients in
the study (although 54 of the 67 patients had the in-home care transition visit). Of the 13 patients who
did not have the in-home visit, 8 of the patients had a PCP or Cardiologist office visit within the 7 days
following discharge. This may have contributed to the reason for declining the in-home visit.





Within 7 Days 51 76.12%
Within 14 Days 13 19.40%
Within 21 Days 3 4.48%
Total 67 100.00%
Table 10: Study Participant Follow-up Visit Timing
In the same 6 month period (July- December) of the prior year, the study hospital’s 30-day all-cause
(same facility) readmission rate for CHF patients in the 65+ age group was 14.75%. When examining the
subset of these patients that would have been candidates for the care transition program had the
program existed (i.e. those 65+, CHF, traditional Medicare, discharged direct to home, without home
health), that subpopulation’s 30-day all-cause (same facility) readmission rate was 12.96%.
Commentary
Limitations
Based on the limited number of study participants to date, caution should be taken in interpreting
definitive outcome changes as a result of the program. While the study population was small (67
patients) the outcome of the study demonstrates the potential effectiveness of the program. The
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methods for care delivery in the outpatient setting (the in-home visit) were well suited to the Southeast
Texas region, however this study took place in a small rural facility, and as such, its implications and
effectiveness in other settings may be different.
Also, by nature, patients discharged home to self-care are typically healthier than those being
discharged to SNFs or rehabs or other post-acute care. This study did not set out to compare
differences in readmission rates across different venues (i.e., SNF vs. in-home transitional care program
or home health vs. in-home transitional care program) but rather to establish the in-home transitional
care program as a viable option for consideration in a hospital’s overall readmission reduction efforts.
Discussion
The home-visit based program described here serves as a trial demonstration for leveraging a care
transition program to bridge the gap between discharge and next level of care. No patients initially
enrolled in the study were readmitted within 30 days post discharge. Successful conversion (67 patients
enrolled and 54 patients completing the in-home visit) demonstrates the effectiveness of the program in
how it was presented to the patient (introductory face to face handoff by hospital staff, introductory
letter, reinforcing phone call).
This initial trial of the program demonstrates the potential effectiveness of a home-based care transition
program with the following elements: 1)approaching patients early in the inpatient stay; 2)immediate
contact with the patient following discharge (within 24 hours); 3) early in-home visit conducted by the
care team (within 72 hours); 4) continued touchpoints by the care transition team through 30 days post
discharge via telephone support; and 5) availability of a telephone support for the patient to utilize if
they are experiencing symptom exacerbation. Further attention should be given to scaling the program
and capturing a larger share of the discharged-to-home (self-care) population.
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As inpatient demand is often outpacing bed and/or staff availability in Southeast Texas, reducing
preventable admissions of patients with chronic conditions is increasingly important. CMS pressure to
reduce preventable readmissions by penalizing hospitals with higher-than-average readmissions further
emphasizes the importance of platforms like this care transition program.
The 2013 American Heart Association/American College of Cardiology (AHA/ACC) Heart Failure
guidelines addressed post discharge HF specific interventions. These guidelines focus on the importance
of optimizing HF pharmacotherapy before discharge, providing HF education before discharge (including
self-care management), and addressing barriers to care among other factors. These guidelines included
a follow-up visit within 7 to 14 days of discharge or a telephone follow-up within 3 days of discharge134.
The AHA/ACC guidelines also recommend initiating multidisciplinary HF disease management programs
for patients at high risk for readmission135. However, the AHA/ACC did not provide definitive guidance
on the recommended components of transitional care interventions aimed at preventing readmissions
for patients with HF.
In concert with the AHA/ACC guidelines and based on a review of the literature discussed here, five
elements seem to be effective themes for addressing all-cause readmissions, including:
1. Education focused on self-care, which can be instituted prior to discharge and reinforced
throughout the transition of care episode. In this demonstration, education began in the
inpatient setting by the care transition coordinator and the hospital’s heart failure clinician.
2. Focus on pharmacotherapy and the importance of ensuring access to home medications and
adherence to their prescription regimen. The care transition coordinator focused on medication
reconciliation prior to discharge and also at the in-home visit to ensure that the patient was
able to acquire the needed medications, was educated on taking the medications (frequency,
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purpose, instructions) and understood the importance of taking the medications per the
doctor’s orders.
3. Early contact following discharge (which can come in the form of a home visit or outpatient
follow-up) to help ensure any home based lifestyle barriers are mitigated. The program
described here made contact with the patient within 24 hours by phone and within the first 72
hours (goal) with the in-home visit.
4. A process for patients to contact personnel as problems arise or symptoms worsen (e.g.,
telephone support). The same call center that made outbound calls to the patient was also
capable of taking in-bound calls from the patient based on questions or concerns that the
patient had.
5. A mechanism that allows the intervention to be individualized to the patient’s specific needs
(including early adjustment of medications based on symptoms). All of the education was
tailored to the individual patient’s needs and learning comprehension.
The care transition program described here includes all five of these elements that are outlined by the
AHA/ACC. Initial success in this program demonstrates the potential benefit to scaling this effort to
reach a larger percentage of the CHF discharged population. In addition, future endeavors may expand
to other chronic care disease states beyond CHF.
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Supporting Tables
Supplemental Table 1: Disease Management Clinic Enrollees by Month
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Grand Total 67 100%






African American/Black 16 23.9%
Peoples-Euro/MidEast 51 76.1%
Grand Total 67 100%








1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47
Disease ManagementClinic







HOME HEALTH SERVICES 45 298 15.1%
HOME, SELF-CARE 82 688 11.9%
LONG TERM CARE 12 56 21.4%
REHAB FACILITY 7 37 18.9%
SKILLED NURSING FACILITY 29 203 14.3%
Grand Total 175 1282 13.7%
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In-home visit encounter detail:
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7/26/2017 7/26/2017 7/27/17 ADMITED TO HH --------------- -------------
7/31/17,
YES CHF, N
8/2/2017 8/1/2017 8/3/2017 8/4/2017 8/10/2017 8/18/2017 8/25/2017
8/23/17,
YES CHF, N





8/2/2017 8/2/2017 8/3/2017 8/8/2017 8/10/2017 8/17/2017 8/24/2017 8/9/17, YES CHF, N
8/9/2017 8/9/2017 8/10/2017 8/11/2017 8/18/2017 8/25/2017 9/11/2017
9/11/17,
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YES CHF, N
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11/7/2017 11/6/2017 11/8/2017 Declined Declined NA NA
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